The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials

In recent years, chimeric antigen receptor (CAR) T-cell therapy has emerged as an effective and potentially paradigm-shifting therapy for patients with refractory lymphoma and myeloma. This novel therapy involves engineering T cells to recognize specific antigens on the surface of cancer cells. Seve...

Descripción completa

Detalles Bibliográficos
Autor principal: Dsouza, Ly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894206/
https://www.ncbi.nlm.nih.gov/pubmed/36741214
http://dx.doi.org/10.6004/jadpro.2023.14.1.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894206/
https://www.ncbi.nlm.nih.gov/pubmed/36741214
http://dx.doi.org/10.6004/jadpro.2023.14.1.5

Ejemplares similares